Bropirimine
Drug profile
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Bropirimine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including XDH.
- Molecular targets: XDH (1 listed in DrugCentral).
- Molecular formula: C10H8BrN3O; molecular weight 266.10 g/mol.
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Xanthine dehydrogenase/oxidase | XDH | unknown | IC50 6.00 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Bropirimine is on its molecule page.
| Molecular formula | C10H8BrN3O |
|---|---|
| Molecular weight | 266.10 g/mol |
| CAS number | 56741-95-8 |
| InChIKey | CIUUIPMOFZIWIZ-UHFFFAOYSA-N |
| PubChem CID | 135413497 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Bropirimine work?
Its molecular targets in DrugCentral include XDH.
What is the chemical formula of Bropirimine?
Bropirimine has the molecular formula C10H8BrN3O and a molecular weight of 266.10 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3689 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL37387 — compound record and bioactivity
- PubChem CID 135413497 — chemical identifiers
- DrugBank DB04168 — drug record
- FDA UNII J57CTF25XJ — substance identity
- UniProt P47989 (XDH) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.